Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Status:
Completed
Trial end date:
2018-06-07
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the bioequivalency between the test formulations of
extended-release tablet of cilostazol (PMR) administered once-daily and the reference
formulation of immediate-release tablet of cilostazol (Cilostazol) administered twice-daily
in normal healthy male and female subjects under fasting conditions.